A detailed history of Mwa Asset Management transactions in Abb Vie Inc. stock. As of the latest transaction made, Mwa Asset Management holds 16,576 shares of ABBV stock, worth $2.82 Million. This represents 2.18% of its overall portfolio holdings.

Number of Shares
16,576
Previous 16,534 0.25%
Holding current value
$2.82 Million
Previous $2.84 Billion 15.42%
% of portfolio
2.18%
Previous 2.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$163.84 - $199.33 $6,881 - $8,371
42 Added 0.25%
16,576 $3.27 Billion
Q2 2024

Jul 26, 2024

BUY
$154.79 - $180.76 $40,400 - $47,178
261 Added 1.6%
16,534 $2.84 Billion
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $105,001 - $119,639
657 Added 4.21%
16,273 $2.96 Billion
Q4 2023

Jan 23, 2024

BUY
$137.6 - $154.97 $122,464 - $137,923
890 Added 6.04%
15,616 $2.42 Billion
Q3 2023

Oct 27, 2023

BUY
$133.59 - $154.65 $1.97 Million - $2.28 Million
14,726 New
14,726 $2.2 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $301B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mwa Asset Management Portfolio

Follow Mwa Asset Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mwa Asset Management, based on Form 13F filings with the SEC.

News

Stay updated on Mwa Asset Management with notifications on news.